Tabell
Hovedbudskap |
|
- 1.
van der Velde N, Stricker BH, Pols HA et al. Risk of falls after withdrawal of fallrisk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol 2007; 63: 232–7.
- 2.
Graves T, Hanlon JT, Schmader KE et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997; 157: 2205–10.
- 3.
Coulson J, Routledge PA. Adverse reactions to drug withdrawal. Adverse Drug React Bull 2008; 252: 967–70.
- 4.
Lundgren C. FAS-UT. Råd vid utvärding och avslutning av läkemedelsbehandling. Klippan: Ljungbergs Tryckeri, 2005.
- 5.
Castberg I. Seponeringssyndrom etter behandling med antidepressiver. Tidsskr Nor Lægeforen 2004; 124: 2493-4.
- 6.
Lader M, Tylee A, Donoghue J. Withdrawing benzodiazepines in primary care. CNS Drugs 2009; 23: 19–34.
- 7.
Mouland G. Praktiske råd om nedtrapping av benzodiazepiner. Tidsskr Nor Lægeforen 2001; 121: 2394-5.
- 8.
Bain KT, Holmes HM, Beers MH et al. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008; 56: 1946–52.
- 9.
Lordkipanidzé M, Diodati JG, Pharand C. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence. Pharmacol Ther 2009; 123: 178–86.
- 10.
Black DM, Schwartz AV, Ensrud KE et al. Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Longterm Extension (FLEX): a randomized trial. JAMA 2006; 296: 2927–38.
- 11.
Iyer S, Naganathan V, McLachlan AJ et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008; 25: 1021–31.